Clinical data | |
---|---|
Trade names | Tessalon, others |
Other names | Benzononatine; Egyt-13; KM-65[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682640 |
License data |
|
Routes of administration | By mouth |
Drug class | Antitussives; Local anesthetics; Sodium channel blockers |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Onset of action | 15–20 minutes[3][5] |
Elimination half-life | 1 hour[6][unreliable medical source?] |
Duration of action | 3–8 hours[3][5] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.002.904 |
Chemical and physical data | |
Formula | C30H53NO11 |
Molar mass | 603.750 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Benzonatate, sold under the brand name Tessalon among others, is a medication that is used for the symptomatic relief of cough.[7][8] A 2023 systematic review found that there is inadequate evidence to support the effectiveness and safety of benzonatate for cough and highlighted rising safety concerns.[9] Benzonatate is taken by mouth.[7][5] Effects generally begin within 20 minutes and last 3 to 8 hours.[7][3]
Side effects include sleepiness, dizziness, headache, upset stomach, skin rash, hallucinations, and allergic reactions.[7] Overdosage can result in serious adverse effects including seizures, irregular heartbeat, cardiac arrest, and death.[10][11] Overdose of only a small number of capsules can be fatal.[11] Chewing or sucking on the capsule, releasing the drug into the mouth, can also lead to laryngospasm, bronchospasm, and circulatory collapse.[7] It is unclear if use in pregnancy or breastfeeding is safe.[12] Benzonatate is a local anesthetic and voltage-gated sodium channel blocker.[6][unreliable medical source?] It is theorized to work by inhibiting stretch receptors in the lungs, in turn suppressing the cough reflex in the brain.[6][unreliable medical source?][7] Benzonatate is structurally related to other local anesthetics like procaine and tetracaine.[13][6][unreliable medical source?]
Benzonatate was discovered in 1956 and was approved for medical use in the United States in 1958.[5][7] It is available as a generic medication.[10] Availability worldwide is limited, with the drug remaining marketed only in the United States and Mexico.[14][13][15] In 2022, it was the 130th most commonly prescribed medication in the United States, with more than 4 million prescriptions.[16][17]
Elks2014
was invoked but never defined (see the help page).Tessalon label
was invoked but never defined (see the help page).Homsi2001
was invoked but never defined (see the help page).pmid18771744
was invoked but never defined (see the help page).SchweizerischerApotheker-Verein2000
was invoked but never defined (see the help page).